Overview
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk.
From the notes
| Current income tax (CIT due) | $35,757 |
Filing timeliness
Financial statements were filed on time, on average 62 days early.
- 202505/05/2026
- 202411/04/2025
- 202317/05/2024
- 202224/04/2023
- 202112/07/2022
- 202016/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Anbafarm currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| APTINEA | – |
Authorized Representatives
Manner of representation
One-person management board: President of the Management Board. Multi-member management board: - President of the Management Board - independently, - Vice-President of the Management Board - independently, - two members of the management board - jointly, - one member of the management board and a commercial proxy - jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Jacek Wierzbowskiage 68 | 50 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2006-04-03.
56 1050 1575 1000 0023 0350 0611
38 1440 1387 0000 0000 0748 5727
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,228$4,228 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $5,768$5,768 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,321$4,321 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cefarm RzeszówS.A. | $28,356,418.72 | cefarmrzeszow.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Adpharmasp. z o.o. | $4,026,799.19 | adamed.com | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-12-13 | PKD change (Removed: 34 codes) | |
| 2011-01-17 | Switch to PKD 2007 (52 PKD 2004 codes → 43 PKD 2007 codes) | |
| 2006-03-17 | Entered in the register |
FAQ
Last updated: 2026-10-07